nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—CHRND—pericardium—dilated cardiomyopathy	0.219	0.604	CbGeAlD
Decamethonium—CHRND—heart—dilated cardiomyopathy	0.0338	0.0934	CbGeAlD
Decamethonium—CHRNA2—heart—dilated cardiomyopathy	0.0234	0.0647	CbGeAlD
Decamethonium—CHRNB1—heart—dilated cardiomyopathy	0.0218	0.0602	CbGeAlD
Decamethonium—ACHE—heart—dilated cardiomyopathy	0.0189	0.0522	CbGeAlD
Decamethonium—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0188	0.0295	CbGpPWpGaD
Decamethonium—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0177	0.0277	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—RAC1—dilated cardiomyopathy	0.0162	0.0254	CbGpPWpGaD
Decamethonium—HRH3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0159	0.025	CbGpPWpGaD
Decamethonium—BCHE—cardiac ventricle—dilated cardiomyopathy	0.0141	0.0391	CbGeAlD
Decamethonium—CHRNG—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0141	0.0222	CbGpPWpGaD
Decamethonium—CHRM2—heart—dilated cardiomyopathy	0.014	0.0386	CbGeAlD
Decamethonium—CHRNE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0133	0.0208	CbGpPWpGaD
Decamethonium—HRH3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0129	0.0202	CbGpPWpGaD
Decamethonium—HRH3—Monoamine Transport—AGT—dilated cardiomyopathy	0.0117	0.0183	CbGpPWpGaD
Decamethonium—ACHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.0115	0.0181	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—ABCC9—dilated cardiomyopathy	0.0113	0.0177	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—ACTN2—dilated cardiomyopathy	0.0108	0.017	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—RAF1—dilated cardiomyopathy	0.0107	0.0168	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—ABCC9—dilated cardiomyopathy	0.0106	0.0167	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0105	0.0164	CbGpPWpGaD
Decamethonium—BCHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.0103	0.0161	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—ACTN2—dilated cardiomyopathy	0.0102	0.016	CbGpPWpGaD
Decamethonium—ACHE—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.01	0.0158	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00966	0.0152	CbGpPWpGaD
Decamethonium—BCHE—heart—dilated cardiomyopathy	0.00929	0.0257	CbGeAlD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0089	0.0139	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00845	0.0132	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—RAC1—dilated cardiomyopathy	0.00815	0.0128	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.00805	0.0126	CbGpPWpGaD
Decamethonium—BCHE—cardiac atrium—dilated cardiomyopathy	0.00794	0.0219	CbGeAlD
Decamethonium—CHRND—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00786	0.0123	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.00718	0.0113	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00669	0.0105	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00635	0.00996	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—ABCC9—dilated cardiomyopathy	0.00629	0.00985	CbGpPWpGaD
Decamethonium—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00616	0.00965	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—ACTN2—dilated cardiomyopathy	0.00603	0.00945	CbGpPWpGaD
Decamethonium—ACHE—Monoamine Transport—AGT—dilated cardiomyopathy	0.00558	0.00875	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—RAF1—dilated cardiomyopathy	0.00541	0.00847	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00534	0.00838	CbGpPWpGaD
Decamethonium—HRH3—Monoamine Transport—TNF—dilated cardiomyopathy	0.00529	0.00829	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00527	0.00826	CbGpPWpGaD
Decamethonium—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00517	0.00811	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00512	0.00803	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00508	0.00796	CbGpPWpGaD
Decamethonium—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00499	0.00782	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00487	0.00763	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00457	0.00717	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00437	0.00686	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00437	0.00686	CbGpPWpGaD
Decamethonium—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00428	0.00671	CbGpPWpGaD
Decamethonium—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00419	0.00657	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00407	0.00637	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00406	0.00636	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.00403	0.00632	CbGpPWpGaD
Decamethonium—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00402	0.00631	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00393	0.00616	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0039	0.00611	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00379	0.00594	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00377	0.00591	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00376	0.00589	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00365	0.00573	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.00359	0.00564	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00351	0.0055	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00348	0.00545	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00348	0.00545	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00323	0.00507	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00322	0.00504	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00314	0.00492	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.00314	0.00492	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00313	0.00491	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00312	0.00489	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00302	0.00474	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.00301	0.00472	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00296	0.00464	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00287	0.0045	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00282	0.00443	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.0028	0.00439	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00276	0.00432	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.00269	0.00421	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00267	0.00419	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00265	0.00415	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00265	0.00415	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00259	0.00406	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.00255	0.004	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00254	0.00398	CbGpPWpGaD
Decamethonium—ACHE—Monoamine Transport—TNF—dilated cardiomyopathy	0.00253	0.00397	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—RAF1—dilated cardiomyopathy	0.00246	0.00386	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00246	0.00386	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00246	0.00385	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00238	0.00374	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00238	0.00373	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00237	0.00371	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—RAF1—dilated cardiomyopathy	0.00232	0.00363	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00231	0.00362	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.00228	0.00357	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00224	0.00351	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00224	0.00351	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00222	0.00347	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00204	0.00319	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00202	0.00317	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.002	0.00313	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.002	0.00313	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00193	0.00303	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00192	0.00301	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00188	0.00295	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00184	0.00289	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00179	0.00281	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00152	0.00239	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00152	0.00238	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0015	0.00235	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0015	0.00235	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00149	0.00234	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00148	0.00232	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00147	0.0023	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00145	0.00227	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00143	0.00225	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00143	0.00224	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00142	0.00223	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00142	0.00223	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.0014	0.00219	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00139	0.00218	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—RAF1—dilated cardiomyopathy	0.00137	0.00215	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00136	0.00213	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00136	0.00213	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00135	0.00211	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00132	0.00207	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00132	0.00207	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00127	0.00199	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00126	0.00198	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ANKRD1—dilated cardiomyopathy	0.00123	0.00192	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00123	0.00192	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00122	0.00192	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00119	0.00186	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—RAF1—dilated cardiomyopathy	0.00117	0.00183	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00116	0.00182	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TAZ—dilated cardiomyopathy	0.00115	0.00181	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00115	0.0018	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00113	0.00177	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00113	0.00177	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00111	0.00174	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ANKRD1—dilated cardiomyopathy	0.00109	0.00172	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00109	0.00171	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00105	0.00165	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00104	0.00164	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SDHA—dilated cardiomyopathy	0.00104	0.00164	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TAZ—dilated cardiomyopathy	0.00103	0.00161	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00102	0.0016	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00101	0.00159	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000991	0.00155	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000962	0.00151	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SDHA—dilated cardiomyopathy	0.000931	0.00146	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000928	0.00145	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000904	0.00142	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000894	0.0014	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000881	0.00138	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000869	0.00136	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000861	0.00135	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000861	0.00135	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000848	0.00133	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000825	0.00129	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00081	0.00127	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000803	0.00126	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000803	0.00126	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0008	0.00125	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000798	0.00125	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000786	0.00123	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000775	0.00121	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00077	0.00121	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000769	0.00121	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000769	0.0012	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000761	0.00119	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000746	0.00117	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000735	0.00115	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000723	0.00113	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—RAF1—dilated cardiomyopathy	0.000685	0.00107	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000679	0.00106	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000662	0.00104	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000637	0.000998	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000636	0.000997	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000628	0.000984	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00062	0.000972	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000617	0.000968	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000612	0.000959	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	0.000611	0.000958	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000606	0.00095	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000586	0.000918	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000568	0.00089	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000558	0.000875	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000553	0.000867	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000527	0.000826	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00051	0.0008	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000503	0.000789	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000498	0.000781	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000486	0.000763	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000486	0.000763	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000484	0.000759	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000482	0.000756	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000466	0.00073	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000455	0.000713	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000452	0.000709	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000442	0.000692	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000442	0.000692	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000438	0.000687	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000434	0.000681	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	0.00043	0.000674	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000411	0.000644	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000398	0.000623	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000374	0.000586	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000355	0.000556	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00035	0.000549	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00034	0.000532	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000322	0.000505	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000301	0.000473	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000294	0.000461	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GPX1—dilated cardiomyopathy	0.000283	0.000444	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CD36—dilated cardiomyopathy	0.000276	0.000433	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000275	0.000432	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000263	0.000413	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000261	0.000409	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000261	0.000409	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GPX1—dilated cardiomyopathy	0.000253	0.000396	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00025	0.000392	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—AGT—dilated cardiomyopathy	0.000249	0.00039	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CD36—dilated cardiomyopathy	0.000246	0.000386	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000243	0.00038	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000239	0.000375	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000235	0.000368	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—AGT—dilated cardiomyopathy	0.000222	0.000348	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000207	0.000324	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000201	0.000315	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00019	0.000298	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000166	0.00026	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000164	0.000256	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000148	0.000232	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000141	0.000221	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000114	0.000178	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	9.8e-05	0.000154	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.72e-05	0.000105	CbGpPWpGaD
